Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression
Clinical trial NCT06591091 · RECRUITING
Trial details
- NCT number
- NCT06591091
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-10
- Primary completion
- 2026-12-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.